The Best Healthcare Stocks to Buy With $50 Right Now

Group 1: Healthcare Stocks Overview - Many healthcare stocks, including small-cap biotech companies, are trading below $50 per share, but many are high-risk investments that may not yield long-term wealth for investors [1] - There are high-quality healthcare corporations available for investment at this price point, excluding fractional shares [1] Group 2: Pfizer and Novo Nordisk - Pfizer's shares are currently priced just under $27, trading at 9x forward earnings, significantly lower than the healthcare industry's average forward price-to-earnings of 17.8 [2] - Pfizer has faced inconsistent financial results, primarily due to lower sales from its coronavirus franchise, but is expected to improve as dependence on these products declines [3] - Novo Nordisk's stock price is around $39 with a forward price-to-earnings ratio of 10.4, and it is well-positioned to benefit from the expanding weight-loss market [3] - Novo Nordisk's weight-loss medicines, such as Wegovy, are leaders in their niches, and the company has several pipeline candidates that could receive approval in the coming years [4] Group 3: Exelixis - Exelixis, while not a major name in biotech, has established a niche in oncology with its therapy Cabometyx, which treats certain forms of liver and kidney cancer [5] - The company has been reporting growing revenue and earnings, and it may achieve further label expansions for Cabometyx before facing generic competition in early 2030 [5]